Camden National Corp. logo CAC - Camden National Corp.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 4
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $53.67 DETAILS
HIGH: $58.00
LOW: $50.00
MEDIAN: $53.00
CONSENSUS: $53.67
DOWNSIDE: 0.11%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Undervalued Moderate
Trading 28.9% below fair value
Current Price $53.73
Bear Case $48.26 10.2% downside ($48.26 - $53.73) / $53.73 = -10.2% ROTCE 9.7% → 1.74x TBV
Fair Value $75.58 40.7% upside ($75.58 - $53.73) / $53.73 = 40.7% ROTCE 13.0% → 2.73x TBV
Bull Case $91.97 71.2% upside ($91.97 - $53.73) / $53.73 = 71.2% ROTCE 14.9% → 3.32x TBV

Adjust Assumptions

13.0%
7.3%

Key Value Driver

ROTCE (13.0%) vs. cost of equity (7.3%)

Implied Market Multiple 1.81x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $53.67 from 6 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $75.58 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Dividend-based valuation: $29.43 (64% below our primary estimate). Large gaps suggest the dividend may not fully reflect the company's value.
Wall Street's average price target is $53.67 (from 6 analysts). Our estimate is 51% above the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly